Showing results (1341-1350 of 1,449) with videos related to

Sort By:
Pageof 145
European Urology|December 14, 2011
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancerAlberto Briganti, Steven Joniau, Paolo Gontero, et al.
The Oncologist|October 1, 2025
Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutationFabian Kleinhenz, Nicole Pfarr, Lisa Steinhelfer, et al.
Blood Neoplasia|April 20, 2026
Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphomaDeniz Özistanbullu, Karola Bahrami, Monika Doll, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|September 16, 2017
[Biologic Reconstruction of Full Sized Cartilage Defects of the Hip: A Guideline from the DGOU Group "Clinical Tissue Regeneration" and the Hip Committee of the AGA]Stefan Fickert, Matthias Aurich, Dirk Albrecht, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 1998
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patientsS L Kwa, J V Lebesque, J C Theuws, et al.
Urologic Oncology|February 11, 2015
Natural history of surgically treated high-risk prostate cancerAlberto Briganti, Robert Jeffrey Karnes, Giorgio Gandaglia, et al.
Blood Advances|February 28, 2025
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphomaDeniz Özistanbullu, Raphael Wilhelm, Gabi Reichenbach, et al.
Anaesthesia|January 14, 2024
Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trialJ Fechner, K El-Boghdadly, D R Spahn, et al.
European Urology|September 11, 2012
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysisAlberto Briganti, Martin Spahn, Steven Joniau, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
Pageof 145